Omalizumab Subcutaneous and Omeclamox-Pak
Determining the interaction of Omalizumab Subcutaneous and Omeclamox-Pak and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: amoxicillin / clarithromycin / omeprazole
Brand name: Omeclamox-Pak
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Omega-3 Fatty Acids
- Omalizumab Subcutaneous-Omega-3 polyunsaturated fatty acids
- Omalizumab Subcutaneous-Omega-3-acid ethyl esters
- Omalizumab Subcutaneous-Omega-3-carboxylic acids
- Omalizumab Subcutaneous-Omegaven
- Omeclamox-Pak-Ombitasvir, Paritaprevir, and Ritonavir
- Omeclamox-Pak-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Omeclamox-Pak-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Omeclamox-Pak-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Omeclamox-Pak-Omega-3 Fatty Acid Capsules
- Omeclamox-Pak-Omega-3 Fatty Acids